Siemens Healthcare GmbH, MI, Knoxville, TN, USA.
J Nucl Cardiol. 2018 Aug;25(4):1400-1411. doi: 10.1007/s12350-018-1262-3. Epub 2018 Apr 10.
Cardiac PET/CT is an evolving, non-invasive imaging modality that impacts patient management in many clinical scenarios. Beyond offering the capability to assess myocardial perfusion, inflammatory cardiac pathologies, and myocardial viability, cardiac PET/CT also allows for the non-invasive quantitative assessment of myocardial blood flow (MBF) and myocardial flow reserve (MFR). Recognizing the need for an enhanced comprehension of coronary physiology, Siemens Healthineers implemented a sophisticated solution for the calculation of MBF and MFR in 2009. As a result, each aspect of their innovative scanner and image-processing technology seamlessly integrates into an efficient, easy-to-use workflow for everyday clinical use that maximizes the number of patients who potentially benefit from this imaging modality.
心脏 PET/CT 是一种不断发展的非侵入性成像方式，在许多临床情况下都影响着患者的管理。心脏 PET/CT 不仅能够评估心肌灌注、炎症性心脏病变和心肌活力，还可以进行非侵入性的心肌血流（MBF）和心肌血流储备（MFR）定量评估。西门子医疗为了增强对冠状动脉生理学的理解，于 2009 年实施了一种用于计算 MBF 和 MFR 的复杂解决方案。因此，其创新扫描仪和图像处理技术的各个方面都无缝地融入到日常临床应用的高效、易用的工作流程中，使更多可能受益于这种成像方式的患者从中获益。
